Peptide library, A to Z

A GHRH analog studied for growth-hormone release, recovery, lean mass, and sleep quality.

A GHRH-analog and GHRP blend studied for growth-hormone release and recovery.

A myostatin-binding protein studied for muscle hypertrophy via activin inhibition.

A follistatin isoform studied for systemic myostatin inhibition and lean-mass preservation.

A follistatin isoform studied for local myostatin inhibition and muscle hypertrophy.

A growth-hormone-releasing peptide studied for strong GH release and lean mass.

A growth-hormone-releasing peptide studied for GH release and strong appetite stimulation.

A potent growth-hormone-releasing peptide studied for GH release and cardiac protection.

A growth-hormone and IGF-1 stack studied for muscle accrual and recovery during dosing.

A truncated IGF-1 analog studied for localized muscle growth with high potency.

A long-acting IGF-1 analog studied for muscle growth and cellular proliferation.

A selective growth-hormone-releasing peptide studied for clean GH release and recovery.

An IGF-1 splice-variant peptide studied for satellite-cell activation and muscle repair.

An oral ghrelin-receptor agonist studied for raising growth hormone, sleep, and lean mass.

A pegylated IGF-1 splice variant studied for systemic muscle-repair signaling.

A GHRH analog studied for pulsatile growth-hormone release, sleep, and anti-aging.

Recombinant human growth hormone studied for lean mass, fat loss, and bone density.

An FDA-approved GHRH analog studied for reducing visceral abdominal fat and triglycerides.

A blend of Tesamorelin and Ipamorelin studied for visceral-fat reduction and recovery.

An NNMT-inhibitor small molecule studied for raising NAD+ and supporting fat metabolism.

An experimental peptide studied for targeting fat-tissue blood supply to drive fat loss.

An AMPK-activator nucleoside studied as an exercise mimetic for fat oxidation and endurance.

A growth-hormone fragment studied for fat loss and lipolysis without affecting blood sugar.

A long-acting amylin analog studied for appetite suppression and meaningful weight loss.

A blend of amylin and GLP-1 agonists studied for strong appetite control and weight loss.

A GLP-1 receptor agonist studied for type-2 diabetes control and modest weight loss.

An investigational amylin-receptor agonist studied for appetite control and weight loss.

A GLP-1 receptor agonist studied for diabetes control and weight loss of roughly 5 to 10%.

A dual GLP-1/glucagon agonist studied for weight loss, glucose control, and liver fat.

A mitochondrial-derived peptide studied for insulin sensitivity and metabolic support.

An oral GLP-1 agonist studied for weight loss and blood-sugar control without injection.

A short peptide bioregulator studied for pancreatic beta-cell glucose support.

A triple GIP/GLP-1/glucagon agonist studied for large weight loss and metabolic effects.

A GLP-1 receptor agonist studied for blood-sugar control and substantial weight reduction.

An ERR-agonist small molecule studied as an exercise mimetic for endurance and fat loss.

A dual GLP-1/glucagon agonist studied for large weight loss and fatty-liver-disease benefit.

A triple monoamine reuptake inhibitor studied for appetite suppression and weight loss.

A dual GIP/GLP-1 receptor agonist studied for major weight loss and blood-sugar control.

An EPO-derived peptide studied for small-fiber neuropathy pain and tissue protection.

A synthetic peptide studied for tendon, muscle, and gut-lining repair and reduced inflammation.

A blend of BPC-157 and KPV studied for gut-lining repair and inflammatory-bowel support.

A short peptide bioregulator studied for bronchial and respiratory mucosal support.

A short peptide bioregulator studied for cardiac tissue support in animal models.

A short peptide bioregulator studied for lung and bronchial epithelial support.

A signaling tripeptide studied for tissue repair, collagen support, and wound healing.

A copper-tripeptide studied for collagen synthesis, skin anti-aging, and wound healing.

A regenerative peptide blend studied for skin renewal, wound recovery, and collagen support.

A regenerative peptide blend studied for inflamed-tissue and mucosal repair and recovery.

An alpha-MSH-derived tripeptide studied for anti-inflammatory and gut-barrier effects.

A short peptide bioregulator studied for liver tissue and hepatocyte function support.

A host-defense peptide studied for broad antimicrobial action and wound healing.

A short peptide bioregulator studied for liver and gastrointestinal mucosal support.

A synthetic hexapeptide studied for immune modulation and anti-inflammatory tissue repair.

A thymosin beta-4 fragment studied for tissue repair, angiogenesis, and flexibility.

A short peptide bioregulator studied for bladder mucosa and urinary-function support.

A short peptide bioregulator studied for endothelial function and vascular-aging support.

A peptide blend of BPC-157 and TB-500 studied for synergistic tissue repair and recovery.

A topical copper-tripeptide studied for hair-follicle stimulation and scalp circulation.

A topical peptide studied for softening facial expression lines by easing muscle contraction.

A topical peptide studied for skin brightening and reducing melasma and hyperpigmentation.

A topical signal peptide studied for collagen stimulation, firmness, and wrinkle reduction.

An MC1R agonist studied for tanning and photoprotection in a rare light disorder.

A melanocortin-receptor agonist studied for skin tanning, libido, and appetite effects.

A topical peptide studied for skin brightening and pigment control via MC1R blockade.

A topical lipopeptide studied for hair-follicle stimulation and overall scalp health.

A topical lipopeptide studied for collagen synthesis, skin repair, and anti-aging.

A topical lipopeptide studied for retinol-like skin renewal without the irritation.

A topical peptide studied for reducing expression wrinkles, often paired with Argireline.

A topical lipopeptide studied for anti-inflammaging and reducing skin-aging markers.

A topical peptide studied for wrinkle reduction with a Botox-like relaxing action.

A topical snake-venom-inspired peptide studied for relaxing muscles to smooth wrinkles.

A topical lipopeptide studied for collagen stimulation and reducing wrinkle depth.

A topical tripeptide studied for collagen synthesis and skin-structure support.

A topical peptide studied for muscle relaxation and wrinkle smoothing, a Botox alternative.

A modified Semax analog studied for cognition, focus, and mood, with greater potency.

A neurotrophic peptide mixture studied for stroke, dementia, and brain-injury recovery.

A short peptide bioregulator studied for cortical support and neuroprotection.

An angiotensin-IV analog studied for synaptogenesis and memory via HGF signaling.

A CNTF-derived peptide studied for neurogenesis, synaptic plasticity, and memory.

A spadin-derived peptide studied for antidepressant effects via TREK-1 blockade.

A short peptide bioregulator studied for circadian regulation and neuroprotection.

An anxiolytic tuftsin-analog peptide studied for stress reduction and focus without sedation.

A nootropic ACTH-fragment peptide studied for focus, memory, and neuroprotection.

A short peptide bioregulator studied for cartilage and musculoskeletal support.

A pineal tetrapeptide studied for telomerase activation and circadian-rhythm regulation.

A senolytic peptide studied for clearing senescent cells to extend healthspan.

An endogenous antioxidant tripeptide studied for detoxification, immunity, and skin tone.

A mitochondrial-derived peptide studied for neuroprotection and insulin sensitization.

A cellular coenzyme studied for energy metabolism, DNA repair, and anti-aging.

A mitochondria-targeted tetrapeptide studied for cardiolipin protection and cell energy.

A short peptide bioregulator studied for testicular function and testosterone support.

A short peptide bioregulator studied for thymus support and immune-aging modulation.

A selective estrogen modulator studied for restoring testosterone while preserving fertility.

An FDA-approved GnRH peptide studied for stimulating LH/FSH and testicular function.

An FDA-approved hormone studied for fertility, ovulation, and testosterone support.

A kisspeptin-receptor agonist studied for reproductive-axis activation and libido.

A pituitary hormone studied for labor induction, social bonding, and stress reduction.

An FDA-approved melanocortin agonist studied for libido and arousal in low desire.

An FDA-approved testosterone ester used to treat low testosterone in men, the standard of TRT.

An FDA-approved GnRH agonist studied for prostate cancer, endometriosis, and HPG reset.

An opioid peptide studied in research for analgesia many times stronger than morphine.

An investigational peptide with limited published human data on its researched effects.

An experimental peptide studied for selectively disrupting cancer-cell membranes in vitro.

A short peptide bioregulator studied for prostate-health support in early animal models.

A neuropeptide hormone studied for vasodilation, anti-inflammatory, and gut-function roles.

A short peptide bioregulator studied for immune support and thymic-function recovery.

A short peptide bioregulator studied for thymic function and T-cell modulation.

A thymic peptide studied for immune function, thymus regeneration, and healthy aging.

A thymic peptide studied for immune modulation and T-cell maturation, approved abroad.

A sleep-associated neuropeptide studied for sleep quality and stress modulation.